A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications

Exp Hematol. 2004 Dec;32(12):1255-64. doi: 10.1016/j.exphem.2004.08.007.

Abstract

Objective: Nonmyeloablative conditioning regimens for marrow transplantation are desirable in many settings. Because repeated doses of the antimetabolite 5-fluorouracil (5-FU) decreases marrow long-term repopulating ability (LTRA) upon transplantation into lethally irradiated hosts, we hypothesized that mice given sequential doses of 5-FU (termed paired dose 5-FU) may permit substantial syngeneic marrow engraftment.

Methods: C57Bl/6 or X-linked chronic granulomatous disease (X-CGD) mice were administered 5-FU (150 mg/kg) on days -5 and -1. Assessment of host marrow phenotype and repopulating ability occurred on day 0. Transplantation of syngeneic donor marrow occurred on day 0 or day +15.

Results: We confirmed that the number of Sca-1+lin- cells and the LTRA of marrow from paired dose 5-FU-treated animals were diminished. C57Bl/6 hosts conditioned with paired doses of 5-FU followed by transplantation of 20 x 10(6) fresh B6.SJL marrow cells on day 0 displayed 44.9% +/- 7.1% donor chimerism 2 months posttransplant, and 34.4% +/- 8.6% donor chimerism 6 months posttransplant. In contrast, paired dose 5-FU-conditioned hosts transplanted with similar numbers of donor cells on day +15 exhibited only 3.4% +/- 1.2% donor chimerism at 2 months. Paired dose 5-FU-conditioned X-CGD hosts transplanted with MSCV-m91Neo-transduced X-CGD marrow averaged 6.6% +/- 2.3% (range, 4%-10%) NADPH oxidase-reconstituted neutrophils 12-16 months after transplant.

Conclusion: These findings support the concept that impairment of host stem cell competitiveness may be an important mechanism for permitting engraftment of donor cells, and suggest that only a brief period of modest host stem cell impairment may be necessary to achieve substantial donor cell engraftment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigens, Ly / blood
  • Antimetabolites / administration & dosage*
  • Bone Marrow Transplantation* / immunology
  • Cell Survival / drug effects
  • Cell Survival / radiation effects
  • Fluorouracil / administration & dosage*
  • Graft Survival* / drug effects
  • Graft Survival* / radiation effects
  • Granulomatous Disease, Chronic
  • Hematopoiesis / drug effects
  • Hematopoiesis / radiation effects
  • Hematopoietic Stem Cells / drug effects
  • Hematopoietic Stem Cells / radiation effects
  • Membrane Proteins / blood
  • Mice
  • Mice, Knockout
  • Neutrophils
  • Radiation Chimera* / blood
  • Transplantation Conditioning* / methods
  • Transplantation, Isogeneic
  • Whole-Body Irradiation

Substances

  • Antigens, Ly
  • Antimetabolites
  • Ly6a protein, mouse
  • Membrane Proteins
  • Fluorouracil